India has rejected a drug patent application of a US multi-national pharma company, Abbot Laboratories, paving way for easy access to an important life-saving medication for HIV patients across the globe. Indian Express
India has rejected a drug patent application of a US multi-national pharma company, Abbot Laboratories, paving way for easy access to an important life-saving medication for HIV patients across the globe. Indian Express
Learn more about how you can help build a more equitable system for all